ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies.
In a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis.
We have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated “full service” solution.
Learn more about ICON's heritage and the latest facts and figures about the company.